Welcome to our dedicated page for Bridgewater Bancshares SEC filings (Ticker: BWBBP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bridgewater Bancshares's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bridgewater Bancshares's regulatory disclosures and financial reporting.
Thrivent Financial for Lutherans reports owning 2,382,186 shares of Bridgewater Bancshares Inc. common stock, representing approximately 8.68% of the outstanding shares based on 27,439,946 shares outstanding as of April 29, 2025. The filing is an Amendment No. 7 to a Schedule 13G dated for the event of 06/30/2025 and signed by Thrivent's CFO on 08/15/2025. Thrivent disclaims beneficial ownership of 9,788 shares held in its Defined Benefit Plan Trust and clarifies that 566,140 shares are held by registered investment companies advised by Thrivent Financial for Lutherans while 1,806,258 shares are held by registered investment companies advised by its wholly owned subsidiary Thrivent Asset Management, LLC. The statement affirms the positions were acquired and are held in the ordinary course of business.
Jerry J. Baack, CEO and director reported a non-derivative sale of 10,000 shares of Bridgewater Bancshares, Inc. common stock on 08/12/2025 at a weighted-average price of $16.0066. After the reported sale, the reporting person beneficially owns 1,214,361 shares directly and holds three custodial indirect holdings of 1,000 shares each. The filing discloses the sale price range was $16.00 to $16.12 and offers to provide detailed per-transaction pricing on request.
Bridgewater Bancshares filed a Form 144 reporting a proposed sale of 40,000 shares of Common stock with an aggregate market value of $649,200, to be sold approximately on 08/14/2025 on NASDAQ through broker D.A. Davidson & Co. The filing lists 27,482,534 shares outstanding. Acquisition details show two stock option exercises paid in cash: 25,000 shares acquired on 12/28/2022 and 25,000 on 06/22/2023. The filer reports "Nothing to Report" for securities sold in the past three months and affirms no undisclosed material adverse information.